vs
Montrose Environmental Group, Inc.（MEG）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是Montrose Environmental Group, Inc.的1.1倍（$219.9M vs $193.3M），Orthofix Medical Inc.净利率更高（-1.0% vs -4.3%，领先3.2%），Montrose Environmental Group, Inc.同比增速更快（2.2% vs 2.0%），Montrose Environmental Group, Inc.自由现金流更多（$46.5M vs $16.8M），过去两年Montrose Environmental Group, Inc.的营收复合增速更高（11.5% vs 8.0%）
蒙特罗斯环境集团是一家美国跨国企业，主营各类环境服务，业务覆盖环境行业全产业链，可为公共部门及私营领域客户提供一体化支持。公司总部位于阿肯色州小石城，在美国特拉华州完成注册。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
MEG vs OFIX — 直观对比
营收规模更大
OFIX
是对方的1.1倍
$193.3M
营收增速更快
MEG
高出0.3%
2.0%
净利率更高
OFIX
高出3.2%
-4.3%
自由现金流更多
MEG
多$29.7M
$16.8M
两年增速更快
MEG
近两年复合增速
8.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $193.3M | $219.9M |
| 净利润 | $-8.2M | $-2.2M |
| 毛利率 | 38.6% | 71.1% |
| 营业利润率 | -1.3% | 0.2% |
| 净利率 | -4.3% | -1.0% |
| 营收同比 | 2.2% | 2.0% |
| 净利润同比 | 70.9% | 92.4% |
| 每股收益（稀释后） | $-0.13 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MEGOFIX
| Q4 25 | $193.3M | $219.9M | ||
| Q3 25 | $224.9M | $205.6M | ||
| Q2 25 | $234.5M | $203.1M | ||
| Q1 25 | $177.8M | $193.6M | ||
| Q4 24 | $189.1M | $215.7M | ||
| Q3 24 | $178.7M | $196.6M | ||
| Q2 24 | $173.3M | $198.6M | ||
| Q1 24 | $155.3M | $188.6M |
净利润MEGOFIX
| Q4 25 | $-8.2M | $-2.2M | ||
| Q3 25 | $8.4M | $-22.8M | ||
| Q2 25 | $18.4M | $-14.1M | ||
| Q1 25 | $-19.4M | $-53.1M | ||
| Q4 24 | $-28.2M | $-29.1M | ||
| Q3 24 | $-10.6M | $-27.4M | ||
| Q2 24 | $-10.2M | $-33.4M | ||
| Q1 24 | $-13.4M | $-36.0M |
毛利率MEGOFIX
| Q4 25 | 38.6% | 71.1% | ||
| Q3 25 | 39.4% | 72.2% | ||
| Q2 25 | 43.4% | 68.7% | ||
| Q1 25 | 39.0% | 62.8% | ||
| Q4 24 | 40.8% | 69.0% | ||
| Q3 24 | 40.9% | 68.7% | ||
| Q2 24 | 39.9% | 67.8% | ||
| Q1 24 | 37.8% | 67.5% |
营业利润率MEGOFIX
| Q4 25 | -1.3% | 0.2% | ||
| Q3 25 | 4.4% | -8.3% | ||
| Q2 25 | 6.4% | -7.9% | ||
| Q1 25 | -5.9% | -25.2% | ||
| Q4 24 | -12.1% | -5.3% | ||
| Q3 24 | -0.6% | -9.6% | ||
| Q2 24 | -1.5% | -12.5% | ||
| Q1 24 | -6.5% | -15.6% |
净利率MEGOFIX
| Q4 25 | -4.3% | -1.0% | ||
| Q3 25 | 3.7% | -11.1% | ||
| Q2 25 | 7.8% | -6.9% | ||
| Q1 25 | -10.9% | -27.4% | ||
| Q4 24 | -14.9% | -13.5% | ||
| Q3 24 | -5.9% | -13.9% | ||
| Q2 24 | -5.9% | -16.8% | ||
| Q1 24 | -8.6% | -19.1% |
每股收益（稀释后）MEGOFIX
| Q4 25 | $-0.13 | $-0.05 | ||
| Q3 25 | $0.21 | $-0.57 | ||
| Q2 25 | $0.42 | $-0.36 | ||
| Q1 25 | $-0.64 | $-1.35 | ||
| Q4 24 | $-0.91 | $-0.76 | ||
| Q3 24 | $-0.39 | $-0.71 | ||
| Q2 24 | $-0.39 | $-0.88 | ||
| Q1 24 | $-0.53 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $11.2M | $82.0M |
| 总债务越低越好 | $277.1M | — |
| 股东权益账面价值 | $451.2M | $450.0M |
| 总资产 | $981.3M | $850.6M |
| 负债/权益比越低杠杆越低 | 0.61× | — |
8季度趋势，按日历期对齐
现金及短期投资MEGOFIX
| Q4 25 | $11.2M | $82.0M | ||
| Q3 25 | $6.7M | $62.9M | ||
| Q2 25 | $10.5M | $65.6M | ||
| Q1 25 | $30.3M | $58.0M | ||
| Q4 24 | $12.9M | $83.2M | ||
| Q3 24 | $13.0M | $30.1M | ||
| Q2 24 | $16.9M | $26.4M | ||
| Q1 24 | $9.5M | $27.0M |
总债务MEGOFIX
| Q4 25 | $277.1M | — | ||
| Q3 25 | $302.4M | $157.2M | ||
| Q2 25 | $264.6M | $157.0M | ||
| Q1 25 | $235.6M | $156.9M | ||
| Q4 24 | $204.8M | $157.0M | ||
| Q3 24 | $233.0M | $118.5M | ||
| Q2 24 | $188.7M | $118.0M | ||
| Q1 24 | $280.9M | $118.2M |
股东权益MEGOFIX
| Q4 25 | $451.2M | $450.0M | ||
| Q3 25 | $458.7M | $442.5M | ||
| Q2 25 | $470.3M | $458.3M | ||
| Q1 25 | $444.1M | $458.3M | ||
| Q4 24 | $446.3M | $503.1M | ||
| Q3 24 | $449.2M | $525.9M | ||
| Q2 24 | $448.8M | $546.0M | ||
| Q1 24 | $324.5M | $570.3M |
总资产MEGOFIX
| Q4 25 | $981.3M | $850.6M | ||
| Q3 25 | $985.7M | $832.6M | ||
| Q2 25 | $998.1M | $837.2M | ||
| Q1 25 | $992.2M | $823.1M | ||
| Q4 24 | $990.4M | $893.3M | ||
| Q3 24 | $1.0B | $867.9M | ||
| Q2 24 | $943.9M | $882.0M | ||
| Q1 24 | $918.1M | $906.0M |
负债/权益比MEGOFIX
| Q4 25 | 0.61× | — | ||
| Q3 25 | 0.66× | 0.36× | ||
| Q2 25 | 0.56× | 0.34× | ||
| Q1 25 | 0.53× | 0.34× | ||
| Q4 24 | 0.46× | 0.31× | ||
| Q3 24 | 0.52× | 0.23× | ||
| Q2 24 | 0.42× | 0.22× | ||
| Q1 24 | 0.87× | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $51.9M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $46.5M | $16.8M |
| 自由现金流率自由现金流/营收 | 24.1% | 7.6% |
| 资本支出强度资本支出/营收 | 2.8% | 4.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $91.2M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流MEGOFIX
| Q4 25 | $51.9M | $27.7M | ||
| Q3 25 | $28.1M | $12.4M | ||
| Q2 25 | $21.9M | $11.6M | ||
| Q1 25 | $5.5M | $-18.4M | ||
| Q4 24 | $32.0M | $23.7M | ||
| Q3 24 | $11.4M | $11.7M | ||
| Q2 24 | $894.0K | $9.0M | ||
| Q1 24 | $-22.0M | $-18.6M |
自由现金流MEGOFIX
| Q4 25 | $46.5M | $16.8M | ||
| Q3 25 | $22.3M | $2.5M | ||
| Q2 25 | $19.9M | $4.5M | ||
| Q1 25 | $2.4M | $-25.1M | ||
| Q4 24 | $29.7M | $15.2M | ||
| Q3 24 | $10.2M | $6.3M | ||
| Q2 24 | $-9.8M | $-360.0K | ||
| Q1 24 | $-29.3M | $-29.1M |
自由现金流率MEGOFIX
| Q4 25 | 24.1% | 7.6% | ||
| Q3 25 | 9.9% | 1.2% | ||
| Q2 25 | 8.5% | 2.2% | ||
| Q1 25 | 1.3% | -13.0% | ||
| Q4 24 | 15.7% | 7.0% | ||
| Q3 24 | 5.7% | 3.2% | ||
| Q2 24 | -5.6% | -0.2% | ||
| Q1 24 | -18.9% | -15.4% |
资本支出强度MEGOFIX
| Q4 25 | 2.8% | 4.9% | ||
| Q3 25 | 2.6% | 4.8% | ||
| Q2 25 | 0.8% | 3.5% | ||
| Q1 25 | 1.8% | 3.5% | ||
| Q4 24 | 1.2% | 4.0% | ||
| Q3 24 | 0.6% | 2.7% | ||
| Q2 24 | 6.1% | 4.7% | ||
| Q1 24 | 4.7% | 5.6% |
现金转化率MEGOFIX
| Q4 25 | — | — | ||
| Q3 25 | 3.36× | — | ||
| Q2 25 | 1.19× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MEG
暂无分部数据
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
